Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNSL
4326
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $443K | ﹤0.01% |
114,328
-50,110
| -30% | -$193K |
|
|
OMN
4327
DELISTED
OMNOVA Solutions Inc.
OMN
| $443K | ﹤0.01% |
43,831
-153,656
| -78% | -$1.55M |
|
4328
KRONOS Worldwide
KRO
$681M
| $442K | ﹤0.01% |
33,061
+13,036
| +65% | +$171K |
|
|
SGMO
4329
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $442K | ﹤0.01% |
52,800
-8,600
| -14% | -$79.1K |
|
4330
Lindblad Expeditions
LIND
$2.24B
| $440K | ﹤0.01% |
26,910
+4,180
| +18% | +$66.8K |
|
|
RST
4331
DELISTED
ROSETTA STONE INC
RST
| $440K | ﹤0.01% |
24,255
-4,301
| -15% | -$73.3K |
|
4332
Direxion Daily Small Cap Bear 3x ETF
TZA
$212M
| $439K | ﹤0.01% |
156
+59
| +61% | +$195K |
|
|
AGEN
4333
Agenus
AGEN
$336M
| $438K | ﹤0.01% |
5,489
+1,746
| +47% | +$117K |
|
|
KE
4334
Kimball Electronics
KE
$648M
| $438K | ﹤0.01% |
24,918
+12,412
| +99% | +$204K |
|
|
CIT
4335
CALL
DELISTED
CIT Group Inc.
CIT
| $438K | ﹤0.01% |
9,600
+3,400
| +55% | +$152K |
|
4336
PUT
Fox Class A
FOXA
$24.5B
| $437K | ﹤0.01% |
11,800
-2,400
| -17% | -$82.2K |
|
|
SEI
4337
Solaris Energy Infrastructure
SEI
$3.52B
| $435K | ﹤0.01% |
31,092
-7,124
| -19% | -$85.6K |
|
4338
PUT
Herbalife
HLF
$1.32B
| $434K | ﹤0.01% |
9,100
+1,500
| +20% | +$65K |
|
4339
Ring Energy
REI
$315M
| $433K | ﹤0.01% |
164,102
-48,133
| -23% | -$94.4K |
|
|
AXNX
4340
DELISTED
Axonics, Inc. Common Stock
AXNX
| $433K | ﹤0.01% |
15,628
+8,013
| +105% | +$191K |
|
|
SIEN
4341
DELISTED
Sientra, Inc.
SIEN
| $433K | ﹤0.01% |
4,841
-40,170
| -89% | -$3.03M |
|
4342
CALL
Axalta
AXTA
$8.09B
| $432K | ﹤0.01% |
+14,200
| New | +$419K |
|
4343
HCI Group
HCI
$2.29B
| $432K | ﹤0.01% |
9,456
+2,819
| +42% | +$124K |
|
4344
PUT
Weyerhaeuser
WY
$18.6B
| $432K | ﹤0.01% |
14,300
+1,700
| +13% | +$49.3K |
|
|
REVG
4345
DELISTED
REV Group
REVG
| $431K | ﹤0.01% |
35,278
+21,506
| +156% | +$272K |
|
|
GTS
4346
DELISTED
Triple-S Management Corporation
GTS
| $431K | ﹤0.01% |
23,330
+6,462
| +38% | +$110K |
|
|
AMNB
4347
DELISTED
American National Bankshares Inc
AMNB
| $431K | ﹤0.01% |
10,901
+5,454
| +100% | +$203K |
|
|
LGTY
4348
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $430K | ﹤0.01% |
28,911
+14,398
| +99% | +$226K |
|
|
CDMO
4349
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $430K | ﹤0.01% |
56,064
+28,333
| +102% | +$165K |
|
4350
Amerant Bancorp
AMTB
$1.16B
| $429K | ﹤0.01% |
19,713
+9,898
| +101% | +$206K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.